ConductScience.org, home

Paper17599746

Glucosamine for pain in osteoarthritis: why do trial results differ?

Vlad SC and 3 others. Arthritis Rheum, 2007. Cited by 128 papers, by iCite.

Cite this record

ConductScience Library. Glucosamine for pain in osteoarthritis: why do trial results differ? Papers, record 17599746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599746

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucosamine for pain in osteoarthritis: why do trial results differ?
PubMed
Journal
Arthritis Rheum
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
4.14
iCite
Revised in PubMed
2026-03-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vlad SCSteven C
2LaValley MPMichael P
3McAlindon TETimothy E
4Felson DTDavid T

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucosamineMajor topic
OsteoarthritisMajor topic
PainMajor topic
Clinical Trials as Topic
Humans
Patient Selection
Reproducibility of Results

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
L30 AR054284NIAMS NIH HHSUnited StatesL30AR054284PubMedNIH RePORTER
AR-47785NIAMS NIH HHSUnited StatesP60AR047785PubMed and NIHNIH RePORTER
AR-07598NIAMS NIH HHSUnited StatesT32AR007598PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in17599727The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest.https://conductscience.org/library/papers/17599727PubMed
Comment in18163480Marginal efficacy of glucosamine: comment on the article by VLAD et al and the editorial by Reginster.https://conductscience.org/library/papers/18163480PubMed
Comment in18163508Differing results of trials of glucosamine for pain in arthritis: comment on the article by VLAD et al.https://conductscience.org/library/papers/18163508PubMed

Download CSV of comments and corrections

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
40863703Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.Pharmacy (Basel)2025https://conductscience.org/library/papers/40863703PubMed
40149577Rethinking Osteoarthritis Management: Synergistic Effects of Chronoexercise, Circadian Rhythm, and Chondroprotective Agents.Biomedicines2025https://conductscience.org/library/papers/40149577PubMed
37492361GLUCOSAMINE SULFATE EFFICACY IN TREATING KNEE OSTEOARTHRITIS: A FOLLOW-UP STUDY.Acta Clin Croat2022https://conductscience.org/library/papers/37492361PubMed
36123074Evidence for stratified conflicts of interest policies in research contexts: a methodological review.BMJ Open2022https://conductscience.org/library/papers/36123074PubMed
35431349Broad Medical Uncertainty and the ethical obligation for openness.Synthese2022https://conductscience.org/library/papers/35431349PubMed
35223825Geroprotectors and Skeletal Health: Beyond the Headlines.Front Cell Dev Biol2022https://conductscience.org/library/papers/35223825PubMed
34306677An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting.Ann Med Surg (Lond)2021https://conductscience.org/library/papers/34306677PubMed
31312184Emerging Trend in the Pharmacotherapy of Osteoarthritis.Front Endocrinol (Lausanne)2019https://conductscience.org/library/papers/31312184PubMed
31304125Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature.Rev Bras Ortop2013https://conductscience.org/library/papers/31304125PubMed
31015866Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country.GMS Health Technol Assess2018https://conductscience.org/library/papers/31015866PubMed
297773402017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis.Rheumatol Int2018https://conductscience.org/library/papers/29777340PubMed
29177637
Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Aging Clin Exp Res2018https://conductscience.org/library/papers/29177637PubMed
28292317The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.Trials2017https://conductscience.org/library/papers/28292317PubMed
28207928Industry sponsorship and research outcome.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28207928PubMed
28144573Glucosamine and chondroitin for the treatment of osteoarthritis.World J Orthop2017https://conductscience.org/library/papers/28144573PubMed
27273353Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women.J Nutr Health Aging2016https://conductscience.org/library/papers/27273353PubMed
26936493Feline hip dysplasia: A challenge to recognise and treat.J Feline Med Surg2016https://conductscience.org/library/papers/26936493PubMed
26125195Modifiable lifestyle factors are associated with lower pain levels in adults with knee osteoarthritis.Pain Res Manag2015https://conductscience.org/library/papers/26125195PubMed
26069586The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.Cartilage2011https://conductscience.org/library/papers/26069586PubMed
25369761Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.Arthritis Rheumatol2015https://conductscience.org/library/papers/25369761PubMed

See all 50 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17599746

GET https://conductscience.org/api/papers/v1/17599746/cited_by?page=2